Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997–2020
Clinical Gastroenterology and Hepatology · 2025
DOI: 10.1016/j.cgh.2024.10.021 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025. Verfasst von Henrik Albaek Jacobsen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark; Dep…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Inflammatory Bowel Diseases, Crohn Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish National Research Foundation, Icahn School of Medicine at Mount Sinai.
Abstract (Originalsprache)
BACKGROUND & AIMS: The inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD), are heterogenous diseases ranging from mild to severe. We aimed to describe the prevalence and prognosis of mild IBD in an unselected population-based patient cohort. METHODS: We identified all individuals diagnosed with IBD during 1997 to 2020 in North Denmark (n = 4607). Patients with mild disease, based on treatment history within the first year, were followed for progression to moderate-severe disease, based on a composite outcome of immunomodulators, biologic therapies, IBD-related hospitalization, and/or surgery. We used time-to-event analysis to calculate probabilities of progression based on IBD subtype, age, sex, and duration of mild IBD. RESULTS: Among 2315 individuals with initial mild IBD, 24.5% with UC (n = 474) and 46% with CD (n = 174) progressed to moderate-severe disease during follow-up. Of the total IBD population, 52.3% of patients with UC and 86.8% with CD progressed during follow-up. Individuals
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark; Department of Gastroenterology and Hepatology, Aalborg University Hospita…
- Center for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark.
- Division of Gastroenterology, Crohn's and Colitis Center, Massachusetts General Hospital, Boston, Massachusetts.
- Center for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark; Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division o…
- Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, New York, New York.
Förderung
- Danish National Research Foundation
- Icahn School of Medicine at Mount Sinai
Zitieren
APA
Jacobsen, H. A., Karachalia-Sandri, A., Ebert, A. C., Allin, K. H., Ananthakrishnan, A. N., Agrawal, M., Ungaro, R. C., Colombel, J. F., Larsen, L., & Jess, T. (2025). Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997–2020. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.10.021
Vancouver
Jacobsen HA, Karachalia-Sandri A, Ebert AC, Allin KH, Ananthakrishnan AN, Agrawal M, et al. Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997–2020. Clinical Gastroenterology and Hepatology. 2025. doi:10.1016/j.cgh.2024.10.021
BibTeX
@article{Jacobsen2025,
author = {Jacobsen, Henrik Albaek and Karachalia-Sandri, Anastasia and Ebert, Anthony C and Allin, Kristine H and Ananthakrishnan, Ashwin N and Agrawal, Manasi and Ungaro, Ryan C and Colombel, Jean-Frederic and Larsen, Lone and Jess, Tine},
title = {Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997–2020},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
doi = {10.1016/j.cgh.2024.10.021}
}
EUVIMED